Global demand for the Longhorn Primestore MTM sample collection device has increased significantly due to the Covid-19 pandemic and this has led to an additional $3m+ order expected in May, in addition to the initial $1m order which has already been fulfilled. The majority of these orders are for the core reagent within the device, implying it is a high margin revenue line for EKF. We upgrade our FY20 EBITDA estimates by £0.75m, but see further upside potential this year as and when add
